Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom P Freeman

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
Psychopharmacology|February 28, 2024
The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over studyDaniel Hall, Will Lawn, Shelan Ofori, et al.
Addiction (Abingdon, England)|May 2, 2018
Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawalChandni Hindocha, Tom P Freeman, Meryem Grabski, et al.
Psychopharmacology|January 4, 2023
Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorderRachel Lees, Lindsey A Hines, Chandni Hindocha, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 12, 2022
Acceptability of integrating smoking cessation treatment into routine care for people with mental illness: A qualitative studyKatherine Sawyer, Kim Fredman Stein, Pamela Jacobsen, et al.
International Journal of Environmental Research and Public Health|February 11, 2023
Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey StudyEdith Van Dyck, Koen Ponnet, Tina Van Havere, et al.
Psychological Medicine|February 1, 2018
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the NetherlandsTom P Freeman, Peggy van der Pol, Wil Kuijpers, et al.
Addiction (Abingdon, England)|October 11, 2023
Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over studyDominic Oliver, Amir Englund, Edward Chesney, et al.
The Lancet. Psychiatry|March 19, 2026
The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysisJack Wilson, Olivia Dobson, Andrew Langcake, et al.
Addiction (Abingdon, England)|May 3, 2025
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysisMonika Halicka, Thomas L Parkhouse, Katie Webster, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 15, 2022
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratiosAmir Englund, Dominic Oliver, Edward Chesney, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Psychopharmacology|February 28, 2024
The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over studyDaniel Hall, Will Lawn, Shelan Ofori, et al.
Addiction (Abingdon, England)|May 2, 2018
Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawalChandni Hindocha, Tom P Freeman, Meryem Grabski, et al.
Psychopharmacology|January 4, 2023
Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorderRachel Lees, Lindsey A Hines, Chandni Hindocha, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 12, 2022
Acceptability of integrating smoking cessation treatment into routine care for people with mental illness: A qualitative studyKatherine Sawyer, Kim Fredman Stein, Pamela Jacobsen, et al.
International Journal of Environmental Research and Public Health|February 11, 2023
Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey StudyEdith Van Dyck, Koen Ponnet, Tina Van Havere, et al.
Psychological Medicine|February 1, 2018
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the NetherlandsTom P Freeman, Peggy van der Pol, Wil Kuijpers, et al.
Addiction (Abingdon, England)|October 11, 2023
Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over studyDominic Oliver, Amir Englund, Edward Chesney, et al.
The Lancet. Psychiatry|March 19, 2026
The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysisJack Wilson, Olivia Dobson, Andrew Langcake, et al.
Addiction (Abingdon, England)|May 3, 2025
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysisMonika Halicka, Thomas L Parkhouse, Katie Webster, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 15, 2022
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratiosAmir Englund, Dominic Oliver, Edward Chesney, et al.
Pageof 20